Data from multiple sources - Curated by Toby Galbraith - Last updated 27 February 2017

Latest news articles

Added 1 hour ago Drug news

Oncologic Drugs Advisory Committee recommends Endari (l-glutamine) to treat sickle cell disease.-Emmaus Life Sciences Inc.

Emmaus Life Sciences Inc. announced that the Oncologic Drugs Advisory Committee of the FDA voted 10 to 3 that the...

Added 1 day ago Drug news

Sanofi announces CHMP recommendation for Insulin Lispro Sanofi (insulin lispro 100 Units/mL)a biosimilar for types 1 and 2 diabetes.

Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...

Added 1 day ago Drug news

European Commission grants standard marketing approval for Fampyra (prolonged-release fampridine tablets) to improve walking for MS patients on the basis of ENHANCE study.-Biogen

The European Commission (EC) has granted a standard marketing authorization for Fampyra (prolonged-release fampridine tablets) for walking improvement in people...

View all news articles


Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.


Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients

Visit Oral Anticoagulation Reversal



American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis.

The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees.

Added 3 months ago

NCCN Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

CLL remains the most prevalent adult lerkemia in Wester countries but is considered rare in regions such as East Asia. CLL/SLL comprises approximately 7% of newly diagnosed cases of NHL.

Added 7 months ago

British Guideline on the Management of Asthma

Asthma is a common condition which produces a significant workload for general practice, hospital outpatient clinics and inpatient admissions.

Added 2 years ago

View all guidelines

Journal articles

Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer.

Oral palbociclib (Ibrance®) is a first-in-class, highly selective inhibitor of cyclin-dependent kinases 4 and 6 (i.e. a CDK4/6 inhibitor). It is indicated for the treatment of women with HR-positive, HER2-negative ...

Added 4 days ago

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma.

Prior to 2011, the 1-year survival rates for patients suffering from advanced or metastatic melanoma was as low as 33%, with a median overall survival of about 9 months. Several chemotherapeutic regimens have been applied ...

Added 4 days ago

Olaratumab for advanced soft tissue sarcoma.

Introduction: Olaratumab is a humanized IgG1 monoclonal antibody that blocks the platelet-derived growth factor receptor alpha (PDGFRα). Its antagonistic behavior inhibits the receptor’s tyrosine kinase activity ...

Added 5 days ago

View all journal articles

Clinical trials

Comparison of Propofol and Dexmedetomidine to Treat Hyperactive and Mixed ICU Delirium - the Basel ProDex Randomized Trial

In this randomized study, the investigators aim to test the hypothesis that the reinstitution of a normal circadian rhythm by continuous infusions of dexmedetomidine compared to propofol between 8pm and 6am...

Added 2 months ago

Study of abiraterone acetate plus ADT versus apalatumide versus abiraterone and apalatumide in patients with advanced prostate cancer with non-castrate testosterone levels

Evaluation of the activity, safety and patients reported outcome of ADT plus abiraterone, abiraterone plus APALUTAMIDE (a second-generation antiandrogen) or APALUTAMIDE alone in hormone naïve locally advanced...

Added 7 months ago

Olaparib with or without cediranib in treating patients with metastatic hormone-resistant prostate cancer

This randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with hormone-resistant prostate cancer that has spread to other places in the body.

Added 7 months ago

View all clinical trials

Blog Posts

Fiona Holland

What to say and do when someone has cancer

Posted 3 months ago

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

Liam Farrell

Bad smells are good

Posted 7 months ago

Delicacy is not a virtue in this job.

Monica Caliber

Hypogonadism – why important to diagnose and treat?

Posted 9 months ago

Most clinicians and patients think that the purpose of treating hypogonadism is to merely relieve symptoms. However, this only scratches the surface... 


Treatment Optimisation in Chronic Lymphocytic Leukaemia

Treatment Optimisation in Chronic Lymphocytic Leukaemia
Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
Registration required
Subscription fee

Heart failure: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee

Palliative care in patients with heart failure

Accrediting body
BMJ Learning - British Medical Learning
Credits available
Registration required
Subscription fee
View all CME